Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients

References

• Kovacs JA, Gill VJ, Meshnick S, Masur H. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA 2001; 286: 2450–2460.
   PubMed Web of Science ®Google Scholar
• Sepkowitz KA. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 2002; 34: 1098–1107.
   PubMed Web of Science ®Google Scholar
• Skold O. Sulfonamide resistance: mechanisms and trends. Drug Resist Updat 2000; 3: 155–160.
   PubMed Web of Science ®Google Scholar
• Crothers K, Beard CB, Turner J, . Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 2005; 19: 801–805.
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999; 354: 1347–1351.
   PubMed Web of Science ®Google Scholar
• Huang L, Beard CB, Creasman J, . Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis 2000; 182: 1192–1198.
   PubMed Web of Science ®Google Scholar
• Kazanjian P, Armstrong W, Hossler PA, . Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 2000; 182: 551–557.
   PubMed Web of Science ®Google Scholar
• Ma L, Kovacs JA, Cargnel A, . Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis 2002; 185: 1530–1532.
   PubMed Web of Science ®Google Scholar
• Nahimana A, Rabodonirina M, Zanetti G, . Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. J Infect Dis 2003; 188: 1017–1023.
   PubMed Web of Science ®Google Scholar
• Stein CR, Poole C, Kazanjian P, Meshnick SR. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia. Emerg Infect Dis 2004; 10: 1760–1765.
   PubMed Web of Science ®Google Scholar
• Dallas WS, Gowen JE, Ray PH, Cox MJ, Dev IK. Cloning, sequencing, and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4100. J Bacteriol 1992; 174: 5961–5970.
   PubMed Web of Science ®Google Scholar
• Hampele IC, D'Arcy A, Dale GE, . Structure and function of the dihydropteroate synthase from Staphylococcus aureus. J Mol Biol 1997; 268: 21–30.
   PubMed Web of Science ®Google Scholar
• Kai M, Matsuoka M, Nakata N, . Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene. FEMS Microbiol Lett 1999; 177: 231–235.
   PubMed Web of Science ®Google Scholar
• Wang P, Read M, Sims PF, Hyde JE. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol Microbiol 1997; 23: 979–986.
   PubMed Web of Science ®Google Scholar
• Alvarez-Martinez MJ, Miro JM, Valls ME, . Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients. Diagn Microbiol Infect Dis 2010; 68: 60–65.
   PubMed Web of Science ®Google Scholar
• Alvarez-Martinez MJ, Moreno A, Miro JM, . Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. Diagn Microbiol Infect Dis 2008; 62: 34–43.
   PubMed Web of Science ®Google Scholar
• Costa MC, Helweg-Larsen J, Lundgren B, Antunes F, Matos O. Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveci isolates from Portuguese patients with Pneumocystis pneumonia. Int J Antimicrob Agents 2003; 22: 516–520.
   PubMed Web of Science ®Google Scholar
• Dini L, du Plessis M, Frean J, Fernandez V. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J Clin Microbiol 2010; 48: 2016–2021.
   PubMed Web of Science ®Google Scholar
• Friaza V, Morilla R, Respaldiza N, de la Horra C, Calderon EJ. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain. Postgrad Med 2010; 122: 24–28.
   PubMed Web of Science ®Google Scholar
• Huang L, Welsh DA, Miller RF, . Pneumocystis jirovecii dihydropteroate synthase gene mutations and human immunodeficiency virus-associated Pneumocystis pneumonia. J Eukaryot Microbiol 2006; 53 (Suppl 1): S114–116.
   Google Scholar
• Latouche S, Lacube P, Maury E, . Pneumocystis jirovecii dihydropteroate synthase genotypes in French patients with pneumocystosis: a 1998–2001 prospective study. Med Mycol 2003; 41: 533–537.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Hosoya N, Endo T, . Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J Clin Microbiol 2000; 38: 3161–3164.
   PubMed Web of Science ®Google Scholar
• Valerio A, Tronconi E, Mazza F, . Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype. J Acquir Immune Defic Syndr 2007; 45: 521–528.
   PubMed Web of Science ®Google Scholar
• van Hal SJ, Gilgado F, Doyle T, . Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes. J Clin Microbiol 2009; 47: 1818–1823.
   PubMed Web of Science ®Google Scholar
• Wissmann G, Alvarez-Martinez MJ, Meshnick SR, Dihel AR, Prolla JC. Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients. J Eukaryot Microbiol 2006; 53: 305–307.
   PubMed Web of Science ®Google Scholar
• Beard CB, Carter JL, Keely SP, . Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000; 6: 265–272.
   PubMed Web of Science ®Google Scholar
• Esteves F, Montes-Cano MA, de la Horra C, . Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin Microbiol Infect 2008; 14: 356–362.
   PubMed Web of Science ®Google Scholar
• Kazanjian PH, Fisk D, Armstrong W, . Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China. J Infect Dis 2004; 189: 1684–1687.
   PubMed Web of Science ®Google Scholar
• Elvin KM, Bjorkman A, Linder E, Heurlin N, Hjerpe A. Pneumocystis carinii pneumonia: detection of parasites in sputum and bronchoalveolar lavage fluid by monoclonal antibodies. BMJ 1988; 297: 381–384.
   PubMed Web of Science ®Google Scholar
• Beser J, Botero-Kleiven S, Lebbad M, Hagblom P, Fernandez V. A limited number of ITS haplotypes defines the diversity of Pneumocystis jirovecii strains in Sweden. Inf Genet Evol 2011; 11: 948–954.
   PubMed Web of Science ®Google Scholar
• Kazanjian P, Locke AB, Hossler PA, . Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 1998; 12: 873–878.
   PubMed Web of Science ®Google Scholar
• Smittskyddsinstitutet. [homepage on the internet]. Solna: Swedish Institute for Communicable Disease Control [updated 2009 Sep; cited 2011 Feb 28]. Available at: www.smittskyddsinstitutet.se/statistik/hivinfektion/.
   Google Scholar